Page 86 - 南京医科大学学报自然科学版
P. 86
第43卷第4期
·524 · 南 京 医 科 大 学 学 报 2023年4月
2020,94(10):e1027-e1039 [15] SCHORB E,KASENDA B,ATTA J,et al. Prognosis of pa⁃
[3] KORFEL A,SCHLEGEL U. Diagnosis and treatment of tients with primary central nervous system lymphoma af⁃
primary CNS lymphoma[J]. Nat Rev Neurol,2013,9(6): ter high⁃dose chemotherapy followed by autologous stem
317-327 cell transplantation[J]. Haematologica,2013,98(5):
[4] MENDEZ J S,OSTROM Q T,GITTLEMAN H,et al. The 765-770
elderly left behind⁃changes in survival trends of primary [16] WIEDUWILT M J,VALLES F,ISSA S,et al. Immunoche⁃
central nervous system lymphoma over the past 4 decades motherapy with intensive consolidation for primary CNS
[J]. Neuro Oncol,2018,20(5):687-694 lymphoma:a pilot study and prognostic assessment by dif⁃
[5] PANAGEAS K S,ELKIN E B,DEANGELIS L M,et al. fusion⁃weighted MRI[J]. Clin Cancer Res,2012,18(4):
Trends in survival from primary central nervous system 1146-1155
lymphoma,1975-1999:a population⁃based analysis[J]. [17] LI B,ZHOU P,LIU Y,et al. Platelet⁃to⁃lymphocyte ratio
Cancer,2005,104(11):2466-2472 in advanced cancer:review and meta ⁃ analysis[J]. Clin
[6] HOANG⁃XUAN K,DECKERT M,FERRERI A J M,et al. Chim Acta,2018,483:48-56
European Association of Neuro⁃Oncology(EANO)guide⁃
[18] LI D Y,HAO X Y,MA T M,et al. The prognostic value of
lines for treatment of primary central nervous system lym⁃
platelet⁃to⁃lymphocyte ratio in urological cancers:a meta⁃
phoma(PCNSL)[J]. Neuro Oncol,2023,25(1):37-53
analysis[J]. Sci Rep,2017,7(1):15387
[7] 赵苗苗,徐 卫. 原发中枢神经系统淋巴瘤诊治进展 [19] 罗后宙,陈国强. 外周血中性粒细胞/淋巴细胞比值和
[J]. 南京医科大学学报(自然科学版),2020,40(12): 血小板/淋巴细胞比值预测前列腺癌去势治疗后的病
1879-1884
情进展[J]. 南京医科大学学报(自然科学版),2022,42
[8] ABREY L E,BEN⁃PORAT L,PANAGEAS K S,et al. Pri⁃
(9):1265-1270
mary central nervous system lymphoma:the Memorial
[20] ZHANG M,HUANG X Z,SONG Y X,et al. High platelet⁃
Sloan ⁃ Kettering Cancer Center prognostic model[J]. J
to⁃lymphocyte ratio predicts poor prognosis and clinico⁃
Clin Oncol,2006,24(36):5711-5715
pathological characteristics in patients with breast can⁃
[9] FERRERI A J,BLAY J Y,RENI M,et al. Prognostic scor⁃
cer:a meta ⁃ analysis[J]. Biomed Res Int,2017,2017:
ing system for primary CNS lymphomas:the International
9503025
Extranodal Lymphoma Study Group experience[J]. J Clin
[21] MA W,ZHANG P,QI J,et al. Prognostic value of platelet
Oncol,2003,21(2):266-272
to lymphocyte ratio in hepatocellular carcinoma:a meta⁃
[10] CHUNSONG H,YULING H,LI W,et al. CXC chemokine
analysis[J]. Sci Rep,2016,6:35378
ligand 13 and CC chemokine ligand 19 cooperatively ren⁃
[22] FENG Y,LIU Y,ZHONG M,et al. Complete blood count
der resistance to apoptosis in B cell lineage acute and
score model predicts inferior prognosis in primary central
+
+
chronic lymphocytic leukemia CD23 CD5 B cells[J]. J
nervous system lymphoma[J]. Front Oncol,2021,11:
Immunol,2006,177(10):6713-6722
618694
[11] OYAMA T,YAMAMOTO K,ASANO N,et al. Age⁃relat⁃
[23] GRIVENNIKOV S I,GRETEN F R,KARIN M. Immuni⁃
ed EBV⁃associated B⁃cell lymphoproliferative disorders
ty,inflammation,and cancer[J]. Cell,2010,140(6):
constitute a distinct clinicopathologic group:a study of 96
883-899
patients[J]. Clin Cancer Res,2007,13(17):5124-5132
[24] SHARMA D,BRUMMEL⁃ZIEDINS K E,BOUCHARD B
[12] VILLANO J L,KOSHY M,SHAIKH H,et al. Age,gen⁃
A,et al. Platelets in tumor progression:a host factor that
der,and racial differences in incidence and survival in
primary CNS lymphoma[J]. Br J Cancer,2011,105(9): offers multiple potential targets in the treatment of cancer
[J]. J Cell Physiol,2014,229(8):1005-1015
1414-1418
[25] AMO L,TAMAYO⁃ORBEGOZO E,MARURI N,et al. In⁃
[13] YANG X,WANG Y,SUN X,et al. STAT3 activation is as⁃
volvement of platelet ⁃ tumor cell interaction in immune
sociated with interleukin ⁃ 10 expression and survival in
evasion. Potential role of podocalyxin⁃like protein 1[J].
primary central nervous system lymphoma[J]. World Neu⁃
Front Oncol,2014,4:245
rosurg,2020,134:e1077-e1084
[26] TESFAMARIAM B. Involvement of platelets in tumor cell
[14] LIU C J,LIN S Y,YANG C F,et al. A new prognostic
metastasis[J]. Pharmacol Ther,2016,157:112-119
score for disease progression and mortality in patients
[27] GOODEN M J,DE BOCK G H,LEFFERS N,et al. The
with newly diagnosed primary CNS lymphoma[J]. Cancer
Med,2020,9(6):2134-2145 (下转第541页)